PEGDINETANIB Drug Record

  • PEGDINETANIB chembl:CHEMBL2108356 Antineoplastic

    Alternate Names:

    PEGDINETANIB
    CT-322
    BMS-844203
    VEGFR-2 INHIBITOR PEPTIDE CT-322

    Drug Info:

    FDA Approval not approved
    Drug Class recombinant protein
    Drug Indications antineoplastic agent
    (0 More Sources)

    Publications:

  • PEGDINETANIB   KDR

    Interaction Score: 1.47

    Interaction Types & Directionality:
    inhibitor (inhibitory)

    Interaction Info:
    Notes
    Trial Name CT-322
    Novel drug target Established target

    PMIDs:
    None found


    Sources:
    TALC TdgClinicalTrial TTD

  • TdgClinicalTrial: CT-322

    • Version: January-2014

    Alternate Names:

    Drug Info:
    Drug Indications antineoplastic agent
    Drug Class recombinant protein
    FDA Approval not approved

    Publications:

  • TALC: CT-322

    • Version: 12-May-2016

    Alternate Names:
    CT-322 Primary Drug Name
    CT-322 Drug Synonym

    Drug Info:

    Publications:

  • TTD: Pegdinetanib

    • Version: 2020.06.01

    Alternate Names:
    D0GM6E TTD Drug ID

    Drug Info:

    Publications:

  • ChemblDrugs: chembl:CHEMBL2108356

    • Version: ChEMBL_27

    Alternate Names:

    Drug Info:

    Publications: